Company Profile
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Latest News
What To Expect From Centene’s (CNC) Q2 Earnings
Billionaire Investor Seth Klarman’s Top 5 Stocks: Would He Buy More Today?
Can Humana Beat Q2 Earnings Estimates on Growing Premiums?
The Real Price of UnitedHealth Stock Is Two Years Away
Edwards' Q2 Earnings & Revenues Top Estimates, Stock Rises
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Website | https://www.elevancehealth.com |
| Audit Risk | 9 |
| Board Risk | 1 |
| Overall Risk | 2 |
| Market Cap | 81.91B |
| Trailing P/E | 16.7 |
| Forward P/E | 12.74 |
| Dividend Rate | 6.88 |
| Dividend Yield | 1.82% |
| Trailing Annual Div. Rate | 6.86 |
| Trailing Annual Div. Yield | 1.81% |
| Trailing EPS | 22.62 |
| Forward EPS | 29.63 |
| Book Value | 206.99 |
| Price-to-Book | 1.82 |
| Enterprise-to-Revenue | 0.38 |
| Enterprise-to-EBITDA | 9.08 |
| Short Ratio | 3.47 |
| Ex-Dividend Date | 09/10/2026 |
| Dividend Date | 09/25/2026 |
| Earnings Date | 10/21/2026 |
| Earnings Call Date | 07/15/2026 |
| Earnings Average | 4.66 |
| Earnings Low | 4.55 |
| Earnings High | 4.99 |
| Revenue Average | 49.12B |
| Revenue Low | 48.37B |
| Revenue High | 50.19B |